-

HealthWarehouse.com Announces its Shares of Common Stock Will Trade on the OTCQB Market

CINCINNATI--(BUSINESS WIRE)--HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its shares of common stock have been approved for listing on the OTCQB Market. The shares of common stock will commence trading today under the ticker symbol "HEWA.”

“This listing is an important step to increase investor awareness and interest in Healthwarehouse.com,” said Joseph Peters, President and Chief Executive Officer of the Company. “The shares were previously listed on the OTC Pink Sheets. Listing on the OTCQB will benefit our shareholders by increasing the liquidity of our common stock and providing greater investor exposure.”

OTCQB is operated by the OTC Markets Group Inc. To be eligible for quotation on the OTCQB at otcmarkets.com, companies must be current in their financial reporting and undergo an annual verification and management certification process. Companies must also meet a minimum bid price test and other financial conditions. OTCQB is recognized by the U.S. Securities and Exchange Commission as an established public market and provides current public information to investors who analyze, value, and trade securities.

About HealthWarehouse.com

HealthWarehouse.com, Inc. (OTCQB:HEWA) is America's Leading Online Pharmacy and a pioneer in affordable healthcare. Based in Florence, Kentucky, the Company's services are available nationwide, shipping FDA approved prescription medication and over-the-counter products direct to patients' doors. As one of the first National Association of Boards of Pharmacy (“NABP”) Approved Digital Pharmacies, HealthWarehouse.com services the mission of providing affordable healthcare and incredible patient services to help Americans in all 50 states. Learn more at www.HealthWarehouse.com.

Forward-­Looking Statements

This announcement and the information incorporated by reference herein contain “forward ­looking statements” as defined in federal securities laws, including but not limited to Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995, which statements are based on our current expectations, estimates, forecasts and projections. Statements that are not historical facts, including statements about the beliefs, expectations and future plans and strategies of the Company, are forward-looking statements. Actual results may differ materially from those expressed in forward looking statements or in management's expectations. Important factors which could cause or contribute to actual results being materially and adversely different from those described or implied by forward looking statements include, among others, risks related to competition, management of growth, access to sufficient capital to fund our business and our growth, new products, services and technologies, potential fluctuations in operating results, international expansion, outcomes of legal proceedings and claims, fulfillment center optimization, seasonality, commercial agreements, acquisitions and strategic transactions, foreign exchange rates, system interruption, cyber-attacks, access to sufficient inventory, government regulation and taxation, payments, and fraud. More information about factors that potentially could affect HealthWarehouse.com's financial results is included in HealthWarehouse.com's audited Annual Reports and Quarterly Reports available at otcmarkets.com and prior filings with the Securities and Exchange Commission.

L:\2168\PressRelease-OTCQB.docx

Contacts

Joseph Peters, President and CEO, (800) 748-7001

HealthWarehouse.com, Inc.

OTCQB:HEWA

Release Versions

Contacts

Joseph Peters, President and CEO, (800) 748-7001

More News From HealthWarehouse.com, Inc.

HealthWarehouse.com Reports Full Year 2024 Results

CINCINNATI--(BUSINESS WIRE)--HealthWarehouse.com Reports Full Year 2024 Results...

HealthWarehouse.com Reports Results for Third Quarter 2024

CINCINNATI--(BUSINESS WIRE)--HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and nine months ended September 30, 2024. The Company reported net sales for the third quarter of $9.0 million, an 89% increase over the same period in 2023, resulting from strong growth in prescription sales revenue. The Company reported net income of $74,000 and Adjusted EBITDA, a non-GAAP measure defined below, of $405,000 for the quarter. HealthWarehouse.com, a technolog...

HealthWarehouse.com Reports Results for Second Quarter 2024

CINCINNATI--(BUSINESS WIRE)--HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and six months ended June 30, 2024. The Company reported net sales for the second quarter of 2024 of $5.8 million, a 9% increase over the same period in 2023, resulting from strong growth in partner services and B2C prescription revenue. The Company reported a net loss of $344,000 for the quarter and a net loss of $596,000 for the six months ended June 30, 2024. HealthWareho...
Back to Newsroom